ARK Genomic Revolution ETF (BATS:ARKG – Get Free Report) was the recipient of unusually large options trading on Thursday. Investors purchased 14,158 put options on the stock. This is an increase of approximately 60% compared to the typical volume of 8,868 put options.
ARK Genomic Revolution ETF Price Performance
Shares of BATS:ARKG opened at $23.32 on Friday. The stock has a 50-day moving average price of $28.81 and a 200 day moving average price of $28.43.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in ARKG. Operose Advisors LLC bought a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $25,000. Stephens Consulting LLC bought a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $28,000. LM Advisors LLC bought a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $28,000. Principal Securities Inc. bought a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $32,000. Finally, Allworth Financial LP increased its position in ARK Genomic Revolution ETF by 65.3% during the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock valued at $40,000 after buying an additional 563 shares in the last quarter.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Further Reading
- Five stocks we like better than ARK Genomic Revolution ETF
- Investing in Travel Stocks Benefits
- Comprehensive Analysis of PayPal Stock
- What is a Bond Market Holiday? How to Invest and Trade
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Consumer Staples Stocks, Explained
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.